{"id":61084,"date":"2024-02-28T07:23:46","date_gmt":"2024-02-28T07:23:46","guid":{"rendered":"https:\/\/medsname.com\/thioril\/"},"modified":"2026-04-30T10:23:39","modified_gmt":"2026-04-30T10:23:39","slug":"thioril","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/thioril\/","title":{"rendered":"Thioril"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Hurtigt svar<\/h3>\n

Thioril (Thioridazine 10 \/ 25 \/ 100 mg) is a first-generation phenothiazine antipsychotic. Reserved as last-resort second-line because of the FDA black-box QT warning.<\/p>\n<\/div>\n

\nHvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede kundeanmeldelser<\/a>\n<\/div>\n

\ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n

Hvorfor bestille fra MedsBase<\/h3>\n

Thioril at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy<\/a> \u2014 20-hverdages leveringsvindue eller vi gensender uden ekstra omkostninger \u2014 og kvalificerer sig til vores kundeloyalitetsprogram<\/a>. Verdensomsp\u00e6ndende forsendelse er tilg\u00e6ngelig til de fleste destinationer.<\/p>\n

What Thioril is and how it works<\/h2>\n

Thioril is a Thioridazine tablet supplied by Sun Pharma. Available strengths: 10 \/ 25 \/ 100 mg<\/strong>.<\/p>\n

Thioridazine is a piperidine phenothiazine. It carries an FDA black-box warning for fatal QT prolongation and torsades de pointes<\/strong> and is now reserved as a last-resort second-line antipsychotic \u2014 it was withdrawn or restricted in many jurisdictions in 2000\u20132005. Atypical antipsychotics are preferred for nearly all current indications.<\/p>\n

Indikationer og dosering<\/h2>\n

Reserved for treatment-refractory schizophrenia where atypicals and other typicals have failed. Adult: 50\u2013100 mg TID, max 800 mg\/day. Pre-treatment ECG and electrolyte correction required. Some jurisdictions now require continuous QT monitoring during the first weeks.<\/p>\n

Vigtige sikkerhedsovervejelser<\/h2>\n
\nFDA black-box \u2014 fatal QT and torsades<\/strong><\/p>\n

Thioridazine carries an FDA black-box warning for dose-dependent QT prolongation and torsades de pointes.<\/strong> Reports of sudden cardiac death at therapeutic doses. Pre-treatment ECG mandatory.<\/strong> Contraindicated in known long QT, conduction abnormality, hypokalaemia, hypomagnesaemia, on other QT-prolonging therapy, in CYP2D6 poor metabolisers, and in concurrent strong CYP2D6 inhibitors (paroxetine, fluoxetine, bupropion, quinidine \u2014 all dramatically raise thioridazine levels). Many regulatory agencies have withdrawn thioridazine from the market or restricted to last-resort use; switch to a safer atypical wherever clinically possible<\/strong>.<\/p>\n<\/div>\n

\nAntikolinerg byrde, sedation, ortostatisk hypotension<\/strong><\/p>\n

Alle fenotiaziner har betydelig antikolinerg, antihistamin og \u03b11-blokerende aktivitet. S\u00e6rligt problematisk hos \u00e6ldre \u2014 fald, delirium, urinretention og forstoppelse er almindelige. Undg\u00e5 ved demens, BPH, sn\u00e6vervinklet glaukom, sv\u00e6r leversygdom.<\/p>\n<\/div>\n

\nF\u00f8lsomhed over for lys og hudpigmentering<\/strong><\/p>\n

Fenotiaziner for\u00e5rsager lysf\u00f8lsomhed (alvorlige solskoldninger) og ved langtidsbrug bl\u00e5-gr\u00e5 hudpigmentering og sj\u00e6ldent linse-\/hornhindepigmentering (is\u00e6r chlorpromazin). Solbeskyttelse er obligatorisk.<\/p>\n<\/div>\n

Almindelige bivirkninger<\/h2>\n